Max Robotics — Global Service Robot Directory + US Certification

About

Dongfeng Cheng is a leading pancreatic surgeon whose work has fundamentally advanced the field of minimally invasive pancreatic surgery. His research centers on comparing robotic and laparoscopic approaches to complex pancreatic resections, with a particular focus on improving postoperative outcomes. Cheng’s landmark randomized controlled trial on robot-assisted versus open middle pancreatectomy (50 citations) provided critical evidence for the safety and short-term benefits of the robotic approach. He has also made significant contributions to understanding postoperative complications, notably through a large-scale analysis of 1,465 patients that identified predictive factors for pancreatitis after pancreaticoduodenectomy (48 citations). His comparative studies on minimally invasive distal pancreatectomy for pancreatic neuroendocrine tumors (47 citations) and robotic pancreatectomy for solid pseudopapillary tumors (22 citations) have helped establish evidence-based guidelines for technique selection. Cheng’s pioneering work on robot-assisted middle pancreatectomy in elderly patients (12 citations) further demonstrates his commitment to expanding surgical options for vulnerable populations. With over 170 total citations, his research continues to shape clinical practice in pancreatic surgery worldwide.